Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Moderna hopes to market combined COVID and flu booster in 2023
Source: Politico
Moderna hopes to market a combined booster vaccination for COVID-19, influenza and RSV — a common respiratory virus — as soon as the fall of 2023, CEO Stéphane Bancel said Monday.
Bancel, speaking on a panel at the World Economic Forum, said the combination vaccine would enable people to get broad protection against illnesses caused by respiratory viruses ahead of the winter infectious season without having to obtain multiple jabs.
"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter," said Bancel. "The best-case scenario would be the fall of 2023."
Bancel told investors last September that Moderna was working on a booster shot that would combine its mRNA vaccine for COVID-19, a vaccine it is developing against influenza and possibly a dose to treat respiratory syncytial virus, or RSV.
Bancel, speaking on a panel at the World Economic Forum, said the combination vaccine would enable people to get broad protection against illnesses caused by respiratory viruses ahead of the winter infectious season without having to obtain multiple jabs.
"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter," said Bancel. "The best-case scenario would be the fall of 2023."
Bancel told investors last September that Moderna was working on a booster shot that would combine its mRNA vaccine for COVID-19, a vaccine it is developing against influenza and possibly a dose to treat respiratory syncytial virus, or RSV.
Read more: https://www.politico.eu/article/moderna-hopes-to-market-combined-covid-and-flu-booster-in-2023/
3 replies
= new reply since forum marked as read
= new reply since forum marked as read
